These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9816842)

  • 1. [New therapeutic strategy for autoimmune diseases. 3) Treatment of autoimmune diseases by cytokine signal transduction inhibition].
    Nishimoto N; Yoshizaki K; Kishimoto T
    Nihon Naika Gakkai Zasshi; 1998 Sep; 87(9):1745-50. PubMed ID: 9816842
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of IL-6 for the treatment of inflammatory diseases.
    Nishimoto N; Kishimoto T
    Curr Opin Pharmacol; 2004 Aug; 4(4):386-91. PubMed ID: 15251133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 6: from bench to bedside.
    Nishimoto N; Kishimoto T
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology evaluation: MRA, Chugai.
    Ding C; Jones G
    Curr Opin Mol Ther; 2003 Feb; 5(1):64-9. PubMed ID: 12669473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6: discovery of a pleiotropic cytokine.
    Kishimoto T
    Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S2. PubMed ID: 16899106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic implication of IL-6 blockade.
    Tanaka T; Kishimoto T
    Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.
    Nishimoto N
    Clin Rev Allergy Immunol; 2005 Jun; 28(3):221-30. PubMed ID: 16129906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticytokine therapy in autoimmune diseases.
    Nishimoto N; Kishimoto T; Yoshizaki K
    Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-6 in autoimmune disorders.
    Yoshizaki K; Kuritani T; Kishimoto T
    Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-targeted immunotherapy.
    Janson RW; Arend WP
    Bull Rheum Dis; 1992; 41(3):6-8. PubMed ID: 1617334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castleman disease and associated autoimmune disease.
    Muskardin TW; Peterson BA; Molitor JA
    Curr Opin Rheumatol; 2012 Jan; 24(1):76-83. PubMed ID: 22157415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "new" interleukins.
    Romagnani S
    Allergol Immunopathol (Madr); 1991; 19(3):136-42. PubMed ID: 1799172
    [No Abstract]   [Full Text] [Related]  

  • 14. [A humanized anti-IL-6 receptor antibody(MRA) in RA therapy].
    Hagihara K; Nishimoto N; Yoshizaki K
    Nihon Rinsho; 2002 Dec; 60(12):2401-7. PubMed ID: 12510369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The weight of interleukin-6 in B cell-related autoimmune disorders.
    Youinou P; Jamin C
    J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interleukin-6 in pathogenesis of rheumatoid arthritis].
    Mihara M; Nishimoto N
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():158-62. PubMed ID: 15799337
    [No Abstract]   [Full Text] [Related]  

  • 18. [MRA for therapy of rheumatoid arthritis].
    Nishimoto N; Mihara M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():538-43. PubMed ID: 15799414
    [No Abstract]   [Full Text] [Related]  

  • 19. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
    Quagliata F; Schenkelaars EJ; Ferrone S
    Isr J Med Sci; 1993; 29(2-3):154-9. PubMed ID: 8468170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.